Cargando…

A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone

A comprehensive definition introducing the term “modified mycotoxins” to encompass all possible forms in which mycotoxins and their modifications can occur was recently proposed and has rapidly gained wide acceptance within the scientific community. It is becoming increasingly evident that exposure...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenz, Nicole, Dänicke, Sven, Edler, Lutz, Gottschalk, Christoph, Lassek, Eva, Marko, Doris, Rychlik, Michael, Mally, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331505/
https://www.ncbi.nlm.nih.gov/pubmed/30209771
http://dx.doi.org/10.1007/s12550-018-0328-z
_version_ 1783387146318512128
author Lorenz, Nicole
Dänicke, Sven
Edler, Lutz
Gottschalk, Christoph
Lassek, Eva
Marko, Doris
Rychlik, Michael
Mally, Angela
author_facet Lorenz, Nicole
Dänicke, Sven
Edler, Lutz
Gottschalk, Christoph
Lassek, Eva
Marko, Doris
Rychlik, Michael
Mally, Angela
author_sort Lorenz, Nicole
collection PubMed
description A comprehensive definition introducing the term “modified mycotoxins” to encompass all possible forms in which mycotoxins and their modifications can occur was recently proposed and has rapidly gained wide acceptance within the scientific community. It is becoming increasingly evident that exposure to such modified mycotoxins due to their presence in food and feed has the potential to pose a substantial additional risk to human and animal health. Zearalenone (ZEN) is a well-characterized Fusarium toxin. Considering the diversity of modified forms of ZEN occurring in food and feed, the toxicologically relevant endocrine activity of many of these metabolites, and the fact that modified forms add to a dietary exposure which approaches the tolerable daily intake by free ZEN alone, modified forms of ZEN present an ideal case study for critical evaluation of modified mycotoxins in food safety. Following a summary of recent scientific opinions of EFSA dealing with health risk assessment of ZEN alone or in combination with its modified forms, uncertainties and data gaps are highlighted. Issues essential for evaluation and prioritization of modified mycotoxins in health risk assessment are identified and discussed, including opportunities to improve exposure assessment using biomonitoring data. Further issues such as future consideration of combinatory effects of the parent toxin with its modified forms and also other compounds co-occurring in food and feed are addressed. With a particular focus on ZEN, the most pressing challenges associated with health risk assessment of modified mycotoxins are identified and recommendations for further research to fill data gaps and reduce uncertainties are made.
format Online
Article
Text
id pubmed-6331505
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63315052019-01-27 A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone Lorenz, Nicole Dänicke, Sven Edler, Lutz Gottschalk, Christoph Lassek, Eva Marko, Doris Rychlik, Michael Mally, Angela Mycotoxin Res Original Article A comprehensive definition introducing the term “modified mycotoxins” to encompass all possible forms in which mycotoxins and their modifications can occur was recently proposed and has rapidly gained wide acceptance within the scientific community. It is becoming increasingly evident that exposure to such modified mycotoxins due to their presence in food and feed has the potential to pose a substantial additional risk to human and animal health. Zearalenone (ZEN) is a well-characterized Fusarium toxin. Considering the diversity of modified forms of ZEN occurring in food and feed, the toxicologically relevant endocrine activity of many of these metabolites, and the fact that modified forms add to a dietary exposure which approaches the tolerable daily intake by free ZEN alone, modified forms of ZEN present an ideal case study for critical evaluation of modified mycotoxins in food safety. Following a summary of recent scientific opinions of EFSA dealing with health risk assessment of ZEN alone or in combination with its modified forms, uncertainties and data gaps are highlighted. Issues essential for evaluation and prioritization of modified mycotoxins in health risk assessment are identified and discussed, including opportunities to improve exposure assessment using biomonitoring data. Further issues such as future consideration of combinatory effects of the parent toxin with its modified forms and also other compounds co-occurring in food and feed are addressed. With a particular focus on ZEN, the most pressing challenges associated with health risk assessment of modified mycotoxins are identified and recommendations for further research to fill data gaps and reduce uncertainties are made. Springer Berlin Heidelberg 2018-09-13 2019 /pmc/articles/PMC6331505/ /pubmed/30209771 http://dx.doi.org/10.1007/s12550-018-0328-z Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Lorenz, Nicole
Dänicke, Sven
Edler, Lutz
Gottschalk, Christoph
Lassek, Eva
Marko, Doris
Rychlik, Michael
Mally, Angela
A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone
title A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone
title_full A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone
title_fullStr A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone
title_full_unstemmed A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone
title_short A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone
title_sort critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331505/
https://www.ncbi.nlm.nih.gov/pubmed/30209771
http://dx.doi.org/10.1007/s12550-018-0328-z
work_keys_str_mv AT lorenznicole acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT danickesven acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT edlerlutz acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT gottschalkchristoph acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT lassekeva acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT markodoris acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT rychlikmichael acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT mallyangela acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT lorenznicole criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT danickesven criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT edlerlutz criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT gottschalkchristoph criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT lassekeva criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT markodoris criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT rychlikmichael criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone
AT mallyangela criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone